TGA Cracks Down on Unapproved Peptide Products
10 Jun 2026
Often marketed online for anti-ageing, fitness and muscle-building purposes, many peptide products have not been evaluated for safety, quality or effectiveness. The TGA says the increasing availability of these products has raised concerns about potential health risks for consumers.
Professor Anthony Lawler, head of the TGA, said the regulator regularly updates its compliance priorities based on market trends and emerging risks. Recent enforcement activity involving the TGA, Australian Border Force and Victoria Police led to the seizure of peptides, performance-enhancing substances and illegal steroids valued at more than $2 million.
Because many peptide products are not included on the Australian Register of Therapeutic Goods (ARTG), they have not undergone the checks required for approved therapeutic goods. As a result, some may contain unknown ingredients, be inaccurately labelled or pose health risks when used without medical guidance.
The TGA is increasing compliance action against those involved in the illegal importation, production, promotion and sale of these products. Possible penalties include fines, product seizures and legal proceedings.
Consumers are being advised to avoid purchasing unapproved peptide products from online, overseas or social media sources due to the potential risks to their health and safety.
TGA Cracks Down on Unapproved Peptide Products
Source: Therapeutic Goods Administration (TGA)